|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
70,932,000 |
Market
Cap: |
2.68(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$15.81 - $52.44 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on changing the paradigm for the treatment of rare genetic diseases of obesity, which are characterized by early-onset, severe obesity and hyperphagia, a pathological and insatiable hunger. Co. is developing IMCIVREE (setmelanotide) as a medicine strategy for a subset of individuals who have severe obesity due to genetic variants that impair the melanocortin-4 receptor pathway, a pathway in the brain that is responsible for regulating hunger, caloric intake and energy expenditure, which consequently affect body weight.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
164,376 |
307,851 |
390,685 |
429,469 |
Total Sell Value |
$6,457,019 |
$13,147,582 |
$15,609,906 |
$16,448,857 |
Total People Sold |
7 |
7 |
7 |
8 |
Total Sell Transactions |
10 |
32 |
42 |
61 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shulman Joseph |
Chief Technical Officer |
|
2023-12-28 |
4 |
OE |
$21.38 |
$145,384 |
D/D |
6,800 |
7,926 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2023-12-27 |
4 |
AS |
$50.01 |
$250,796 |
D/D |
(5,015) |
1,126 |
|
-22% |
|
Shulman Joseph |
Chief Technical Officer |
|
2023-12-27 |
4 |
OE |
$21.38 |
$51,312 |
D/D |
2,400 |
6,141 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-12-06 |
4 |
AS |
$40.00 |
$800,000 |
D/D |
(20,000) |
61,406 |
|
2% |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-12-06 |
4 |
OE |
$6.88 |
$137,600 |
D/D |
20,000 |
81,406 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-12-05 |
4 |
AS |
$35.06 |
$246,360 |
D/D |
(7,026) |
61,406 |
|
5% |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-12-05 |
4 |
OE |
$6.88 |
$48,339 |
D/D |
7,026 |
68,432 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-11-24 |
4 |
AS |
$35.02 |
$384,336 |
D/D |
(10,974) |
61,406 |
|
17% |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-11-24 |
4 |
OE |
$6.88 |
$75,501 |
D/D |
10,974 |
72,380 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2023-11-14 |
4 |
AS |
$32.07 |
$894,329 |
D/D |
(27,890) |
3,741 |
|
20% |
|
Shulman Joseph |
Chief Technical Officer |
|
2023-11-14 |
4 |
OE |
$6.80 |
$189,652 |
D/D |
27,890 |
31,631 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-11-14 |
4 |
AS |
$30.38 |
$364,573 |
D/D |
(12,000) |
61,406 |
|
20% |
|
Smith Hunter C |
Chief Financial Officer |
|
2023-11-14 |
4 |
OE |
$6.88 |
$82,560 |
D/D |
12,000 |
73,406 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-11-14 |
4 |
AS |
$32.01 |
$437,819 |
D/D |
(13,677) |
0 |
|
20% |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-11-14 |
4 |
OE |
$6.80 |
$81,804 |
D/D |
12,030 |
13,677 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-11-09 |
4 |
AS |
$27.37 |
$95,183 |
D/D |
(3,438) |
1,647 |
|
51% |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-11-09 |
4 |
OE |
$6.80 |
$23,378 |
D/D |
3,438 |
5,085 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-11-08 |
4 |
AS |
$28.64 |
$165,104 |
D/D |
(5,712) |
1,647 |
|
45% |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-11-08 |
4 |
OE |
$6.80 |
$38,842 |
D/D |
5,712 |
7,359 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-11-03 |
4 |
AS |
$28.00 |
$2,240 |
D/D |
(80) |
1,647 |
|
48% |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-11-03 |
4 |
OE |
$6.80 |
$544 |
D/D |
80 |
1,727 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-09-05 |
4 |
AS |
$28.05 |
$172,958 |
D/D |
(6,166) |
1,647 |
|
60% |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-09-05 |
4 |
OE |
$6.80 |
$30,729 |
D/D |
4,519 |
7,813 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-08-09 |
4 |
AS |
$24.66 |
$42,366 |
D/D |
(1,718) |
3,294 |
|
87% |
|
Chien Jennifer |
EVP, Head of North America |
|
2023-08-09 |
4 |
OE |
$6.80 |
$11,682 |
D/D |
1,718 |
5,012 |
|
- |
|
251 Records found
|
|
Page 3 of 11 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|